• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Evidence that men with familial hypercholesterolemia can avoid early coronary death. An analysis of 77 gene carriers in four Utah pedigrees.

作者信息

Williams R R, Hasstedt S J, Wilson D E, Ash K O, Yanowitz F F, Reiber G E, Kuida H

出版信息

JAMA. 1986 Jan 10;255(2):219-24.

PMID:3941501
Abstract

To study the genetic influence on serum cholesterol levels and early coronary heart disease, 1,134 individuals were screened from 18 Utah pedigrees. In most pedigrees, serum cholesterol appeared to be a purely polygenic trait, with 54% heritability. In four pedigrees with dominant familial hypercholesterolemia, male heterozygotes had a mean serum cholesterol level of 352 mg/dL, myocardial infarction at an average age of 42 years, and coronary death at an average age of 45 years. An informative pedigree structure allowed the identification of four ancestral males born before 1880 who carried this lethal gene and survived to ages 62, 68, 72, and 81 years. This suggests that some healthy life-style factors protected these men against the expression of a gene that has led to coronary disease by age 45 years in all of their heterozygous great-grandsons. One heterozygote showed a drop in serum cholesterol level from 426 to 248 mg/dL, with strict adherence to a low-fat diet without drugs. These observations should help encourage physicians to try harder to identify and help such individuals.

摘要

相似文献

1
Evidence that men with familial hypercholesterolemia can avoid early coronary death. An analysis of 77 gene carriers in four Utah pedigrees.
JAMA. 1986 Jan 10;255(2):219-24.
2
A re-examination of major locus hypotheses for high density lipoprotein cholesterol level using 2,170 persons screened in 55 Utah pedigrees.
Am J Med Genet. 1986 May;24(1):57-67. doi: 10.1002/ajmg.1320240108.
3
Evidence for gene-environmental interactions in Utah families with hypertension, dyslipidaemia and early coronary heart disease.犹他州患有高血压、血脂异常和早期冠心病的家族中基因-环境相互作用的证据。
Clin Exp Pharmacol Physiol Suppl. 1992;20:1-6.
4
Segregation analysis of HDL cholesterol in the NHLBI Family Heart Study and in Utah pedigrees.美国国立心肺血液研究所家族心脏研究及犹他州家系中高密度脂蛋白胆固醇的分离分析。
Eur J Hum Genet. 2002 Jun;10(6):367-74. doi: 10.1038/sj.ejhg.5200818.
5
Mortality in treated heterozygous familial hypercholesterolaemia: implications for clinical management. Scientific Steering Committee on behalf of the Simon Broome Register Group.经治疗的杂合子家族性高胆固醇血症患者的死亡率:对临床管理的启示。代表西蒙·布鲁姆登记组的科学指导委员会。
Atherosclerosis. 1999 Jan;142(1):105-12.
6
Major locus inheritance of apolipoprotein B in Utah pedigrees.
Genet Epidemiol. 1987;4(2):67-76. doi: 10.1002/gepi.1370040202.
7
Multivariate analysis for coronary heart disease in heterozygote familial hypercholesterolemia patients.杂合子家族性高胆固醇血症患者冠心病的多变量分析。
Per Med. 2018 Mar;15(2):87-92. doi: 10.2217/pme-2017-0075. Epub 2018 Jan 31.
8
A novel LDLR mutation, H190Y, in a Utah kindred with familial hypercholesterolemia.在一个患有家族性高胆固醇血症的犹他州家族中发现一种新的低密度脂蛋白受体(LDLR)突变,H190Y。
J Hum Genet. 1999;44(6):364-7. doi: 10.1007/s100380050179.
9
Familial hypercholesterolemia with "normal" cholesterol in obligate heterozygotes.纯合子家族性高胆固醇血症患者胆固醇水平“正常”的情况
Am J Med Genet. 1985 Nov;22(3):585-91. doi: 10.1002/ajmg.1320220317.
10
Coronary risk factors in adolescents related to their knowledge of familial coronary heart disease and hypercholesterolemia: the Muscatine Study.青少年的冠心病风险因素与其对家族性冠心病和高胆固醇血症的认知:马斯卡廷研究
Pediatrics. 1994 Mar;93(3):444-51.

引用本文的文献

1
Is Targeting LDL-C Levels Below 70 mg/dL Beneficial for Cardiovascular and Overall Health? A Critical Examination of the Evidence.将低密度脂蛋白胆固醇(LDL-C)水平降至70mg/dL以下对心血管和整体健康有益吗?对证据的批判性审视。
J Clin Med. 2025 May 20;14(10):3569. doi: 10.3390/jcm14103569.
2
Opinion: Are mental health benefits of the ketogenic diet accompanied by an increased risk of cardiovascular disease?观点:生酮饮食对心理健康有益的同时,是否会增加心血管疾病的风险?
Front Nutr. 2024 May 1;11:1394610. doi: 10.3389/fnut.2024.1394610. eCollection 2024.
3
Mitochondrial Genetic Background May Impact Statins Side Effects and Atherosclerosis Development in Familial Hypercholesterolemia.
线粒体遗传背景可能影响家族性高胆固醇血症患者他汀类药物的副作用和动脉粥样硬化发展。
Int J Mol Sci. 2022 Dec 28;24(1):471. doi: 10.3390/ijms24010471.
4
Genetics of Familial Hypercholesterolemia: New Insights.家族性高胆固醇血症的遗传学:新见解
Front Genet. 2020 Oct 7;11:574474. doi: 10.3389/fgene.2020.574474. eCollection 2020.
5
Polygenic Contribution to Low-Density Lipoprotein Cholesterol Levels and Cardiovascular Risk in Monogenic Familial Hypercholesterolemia.多基因对单基因家族性高胆固醇血症患者低密度脂蛋白胆固醇水平和心血管风险的贡献。
Circ Genom Precis Med. 2020 Oct;13(5):515-523. doi: 10.1161/CIRCGEN.120.002919. Epub 2020 Aug 13.
6
Targeted Genetic Analysis in a Chinese Cohort of 208 Patients Related to Familial Hypercholesterolemia.中国 208 例家族性高胆固醇血症患者的靶向基因分析。
J Atheroscler Thromb. 2020 Dec 1;27(12):1288-1298. doi: 10.5551/jat.54593. Epub 2020 Aug 6.
7
PCSK9 inhibition and the global diabetes epidemic.
Diabetologia. 2017 Apr;60(4):751-752. doi: 10.1007/s00125-017-4217-3. Epub 2017 Jan 29.
8
Long-Term Risk of Atherosclerotic Cardiovascular Disease in US Adults With the Familial Hypercholesterolemia Phenotype.具有家族性高胆固醇血症表型的美国成年人患动脉粥样硬化性心血管疾病的长期风险。
Circulation. 2016 Jul 5;134(1):9-19. doi: 10.1161/CIRCULATIONAHA.116.022335.
9
Temporal trends in lipid screening and therapy among youth from 2002 to 2012.2002年至2012年间青少年血脂筛查与治疗的时间趋势。
J Clin Lipidol. 2015 Sep-Oct;9(5 Suppl):S77-87. doi: 10.1016/j.jacl.2015.06.014. Epub 2015 Jul 9.
10
Pediatric lipid management: an earlier approach.儿科血脂管理:一种更早期的方法。
Endocrinol Metab Clin North Am. 2014 Dec;43(4):981-92. doi: 10.1016/j.ecl.2014.08.004.